The Xaant Resting Autonomic Signature (X-RAS): prospective clinical validation of an autonomic biomarker for anxiety and depressive disorders

Abstract Background Anxiety and depressive disorders affect over 500 million people globally, with a treatment gap exceeding 75% in low- and middle-income countries. Current diagnostic frameworks rely on clinical interview and self-report, with test–retest reliability of 0.20 to 0.67 for these disorders in DSM-5 field trials. Autonomic nervous system dysregulation is a well-established biological correlate of anxiety and depression. We report the first, to our knowledge, prospective clinical validation of an autonomic biomarker-based artificial intelligence system against a blinded psychiatrist reference standard in routine clinical practice. Methods We conducted a prospective, two-site diagnostic accuracy study at tertiary hospitals in Delhi and Kerala, India (CTRI/2023/07/054984). The Xaant Resting Autonomic Signature (X-RAS) platform, a three-layer LSTM with self-attention previously developed on an independent cohort of 2,349 participants and frozen prior to the trial, analysed electrodermal activity and blood volume pulse from 15-minute resting-state recordings and produced a four-class diagnostic classification. Of 180 participants enrolled, 170 completed the protocol. Out of these, 114 clinical participants with DSM-5 depression, anxiety, or comorbid disorders, and 56 reference group participants recruited from a long-term meditation practice tradition were considered. The reference standard was the DSM-5 diagnosis established by the site psychiatrist, who was blinded to the platform output. The primary outcome was Cohen's kappa for AI-psychiatrist diagnostic agreement within the clinical cohort. Results Within the clinical cohort, the platform achieved 93.0% agreement with clinical diagnosis (κ = 0.884, 95% CI 0.789 to 0.956), with 100% sensitivity for generalised anxiety disorder (GAD) detection in the GAD subgroup (n = 15, 95% CI 78.2 to 100). All eight classification disagreements fell along the depression–comorbid boundary, and the AI classification agreed with the patient's own self-categorisation in five of the eight. Performance was consistent across the two sites (Delhi 94.6%, Kerala 91.4%, p = 0.527) and across age, sex, and education subgroups. Classical autonomic markers separated the clinical and reference groups with moderate to large effect sizes (d = 0.53 to 0.84). Two of the physiological constructs of the development-cohort, namely Hypoactivity and Experience, were reproduced at the group level in independently diagnosed patients. A per-minute slope analysis of the tonic EDA signal showed a transdiagnostic reversal, where the baseline settled downward during rest in the reference group and drifted upward across all three clinical subgroups (Kruskal–Wallis p = 3.0 × 10⁻²²). Conclusions Resting-state autonomic AI analysis provides objective diagnostic support for anxiety and depressive disorders, with Cohen’s κ = 0.884 (95% CI 0.789 to 0.956) against psychiatrist-assigned DSM-5 diagnoses in routine outpatient practice. Direct comparison with published inter-rater or test-retest reliability estimates is not appropriate given differences in methodology and reference standards. The platform's low cost, portability, and suitability for non-specialist operators support scalability in resource-limited settings. External validation in primary care, community, telehealth, and non-Indian populations is the next step for the programme. Trial registration: Clinical Trials Registry of India, CTRI/2023/07/054984, registered July 2023.

Authors

Institutions

Publication Details

Journal
Research Square
Published
2026-11-17
DOI
https://doi.org/10.21203/rs.3.rs-11744905/v1
Primary Topic
Heart Rate Variability and Autonomic Control
Type
preprint
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
preprint

The Xaant Resting Autonomic Signature (X-RAS): prospective clinical validation of an autonomic biomarker for anxiety and depressive disorders

Rajlakshmi Borthakur, Cijo Alex, Priya Ranjan Pattanaik, Singh Dharmendra et al.
1 links
Research Square
Heart Rate Variability and Autonomic Control
preprint

The Xaant Resting Autonomic Signature (X-RAS): prospective clinical validation of an autonomic biomarker for anxiety and depressive disorders

Rajlakshmi Borthakur, Cijo Alex, Priya Ranjan Pattanaik, Singh Dharmendra, Saritha Susan Vargese, Priyadarshini Arambam, Philip Matthew, Natwar Sharma
preprint en

Abstract

Abstract Background Anxiety and depressive disorders affect over 500 million people globally, with a treatment gap exceeding 75% in low- and middle-income countries. Current diagnostic frameworks rely on clinical interview and self-report, with test–retest reliability of 0.20 to 0.67 for these disorders in DSM-5 field trials. Autonomic nervous system dysregulation is a well-established biological correlate of anxiety and depression. We report the first, to our knowledge, prospective clinical validation of an autonomic biomarker-based artificial intelligence system against a blinded psychiatrist reference standard in routine clinical practice. Methods We conducted a prospective, two-site diagnostic accuracy study at tertiary hospitals in Delhi and Kerala, India (CTRI/2023/07/054984). The Xaant Resting Autonomic Signature (X-RAS) platform, a three-layer LSTM with self-attention previously developed on an independent cohort of 2,349 participants and frozen prior to the trial, analysed electrodermal activity and blood volume pulse from 15-minute resting-state recordings and produced a four-class diagnostic classification. Of 180 participants enrolled, 170 completed the protocol. Out of these, 114 clinical participants with DSM-5 depression, anxiety, or comorbid disorders, and 56 reference group participants recruited from a long-term meditation practice tradition were considered. The reference standard was the DSM-5 diagnosis established by the site psychiatrist, who was blinded to the platform output. The primary outcome was Cohen's kappa for AI-psychiatrist diagnostic agreement within the clinical cohort. Results Within the clinical cohort, the platform achieved 93.0% agreement with clinical diagnosis (κ = 0.884, 95% CI 0.789 to 0.956), with 100% sensitivity for generalised anxiety disorder (GAD) detection in the GAD subgroup (n = 15, 95% CI 78.2 to 100). All eight classification disagreements fell along the depression–comorbid boundary, and the AI classification agreed with the patient's own self-categorisation in five of the eight. Performance was consistent across the two sites (Delhi 94.6%, Kerala 91.4%, p = 0.527) and across age, sex, and education subgroups. Classical autonomic markers separated the clinical and reference groups with moderate to large effect sizes (d = 0.53 to 0.84). Two of the physiological constructs of the development-cohort, namely Hypoactivity and Experience, were reproduced at the group level in independently diagnosed patients. A per-minute slope analysis of the tonic EDA signal showed a transdiagnostic reversal, where the baseline settled downward during rest in the reference group and drifted upward across all three clinical subgroups (Kruskal–Wallis p = 3.0 × 10⁻²²). Conclusions Resting-state autonomic AI analysis provides objective diagnostic support for anxiety and depressive disorders, with Cohen’s κ = 0.884 (95% CI 0.789 to 0.956) against psychiatrist-assigned DSM-5 diagnoses in routine outpatient practice. Direct comparison with published inter-rater or test-retest reliability estimates is not appropriate given differences in methodology and reference standards. The platform's low cost, portability, and suitability for non-specialist operators support scalability in resource-limited settings. External validation in primary care, community, telehealth, and non-Indian populations is the next step for the programme. Trial registration: Clinical Trials Registry of India, CTRI/2023/07/054984, registered July 2023.

Research Square
Batra Hospital and Medical Research Centre (IN)
Good health and well-being
Heart Rate Variability and Autonomic Control
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon